Efficacy and safety of oral granisetron versus i.v. granisetron in patients undergoing peripheral blood progenitor cell and bone marrow transplantation

scientific article published on 01 February 2000

Efficacy and safety of oral granisetron versus i.v. granisetron in patients undergoing peripheral blood progenitor cell and bone marrow transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/00001813-200002000-00011
P698PubMed publication ID10789597

P50authorThomas CarterQ40548426
P2093author name stringT Pham
V Roy
G B Selby
A M Abang
M H Takemoto
R A Mandanas
P433issue2
P921main subjectgranisetronQ596708
P304page(s)137-142
P577publication date2000-02-01
P1433published inAnti-Cancer DrugsQ4774128
P1476titleEfficacy and safety of oral granisetron versus i.v. granisetron in patients undergoing peripheral blood progenitor cell and bone marrow transplantation
P478volume11

Reverse relations

cites work (P2860)
Q36276557Employment of substandard antiemetic prophylaxis in recent trials of chemotherapy-induced nausea and vomiting
Q35170388Granisetron in the control of nausea and vomiting associated with bone marrow transplantation: a review of its efficacy and tolerability
Q45111044Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.
Q73595859Randomized double-blind study of the Reliefband as an adjunct to standard antiemetics in patients receiving moderately-high to highly emetogenic chemotherapy
Q42660204Randomized open-label trial of dolasetron for the control of nausea and vomiting associated with high-dose chemotherapy with hematopoietic stem cell transplantation

Search more.